Closing out a quiet week on Wall Street, a new SPAC prices its public debut and begins the search for a biotech partner
Biotech’s hot run of IPO pricings appears to be slowing down for the fall, with just a couple of companies making the jump to Wall …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
